Bacampicillin
ANTIINFECTIVES FOR SYSTEMIC USE
Also known as: bacampicillin HCl, bacampicillin hydrochloride, carampicillin
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Bacampicillin is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1980. DrugCentral lists 1 molecular target, including mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB. Recorded indications include Gonorrhea, Haemophilus influenzae pneumonia, Infection of skin AND/OR subcutaneous tissue and Infective otitis media.
- Approval status: ofm (first approved 1980 by the FDA).
- Molecular targets: mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB (1 listed in DrugCentral).
- Indications: Gonorrhea, Haemophilus influenzae pneumonia, Infection of skin AND/OR subcutaneous tissue, Infective otitis media and Pharyngitis and others.
- ATC code: J01CA06 (Penicillins with extended spectrum).
- Molecular formula: C21H27N3O7S; molecular weight 465.52 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (7)
- Gonorrhea
- Haemophilus influenzae pneumonia
- Infection of skin AND/OR subcutaneous tissue
- Infective otitis media
- Pharyngitis
- Sinusitis
- Urinary tract infectious disease
Off-label uses (1)
- Cholangitis
Contraindications (3)
- Infectious mononucleosis
- Kidney disease
- Pseudomembranous enterocolitis
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Bacterial penicillin-binding protein | mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB | inhibitor | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1980-12-22 | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
J01CA06 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › BETA-LACTAM ANTIBACTERIALS, PENICILLINS › Penicillins with extended spectrum |
Chemical structure
| Molecular formula | C21H27N3O7S |
|---|---|
| Molecular weight | 465.52 g/mol |
| CAS number | 50972-17-3 |
| InChIKey | PFOLLRNADZZWEX-FFGRCDKISA-N |
| PubChem CID | 441397 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Bacampicillin used for?
DrugCentral lists the following indications for Bacampicillin: Gonorrhea, Haemophilus influenzae pneumonia, Infection of skin AND/OR subcutaneous tissue, Infective otitis media, Pharyngitis, Sinusitis and Urinary tract infectious disease.
How does Bacampicillin work?
Its molecular targets in DrugCentral include mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB (inhibitor).
When was Bacampicillin first approved?
Bacampicillin was first approved by the FDA in 1980.
What is the chemical formula of Bacampicillin?
Bacampicillin has the molecular formula C21H27N3O7S and a molecular weight of 465.52 g/mol.
Browse: all drugs starting with B · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 280 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200965 — compound record and bioactivity
- PubChem CID 441397 — chemical identifiers
- DrugBank DB01602 — drug record
- FDA UNII 8GM2J22278 — substance identity
- DailyMed: FDA labels for Bacampicillin — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.